arrow
返回
P

Philipp Harter

Department of Gynecology and Gynecologic Oncology

78H指数
754论文数
3.3W被引数
收录论文 117
发表时间
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancerDurvalumab联合卡铂/紫杉醇和贝伐单抗,然后durvalumab和贝伐单抗联合或不联合奥拉帕尼维持治疗新诊断的非BRCA突变晚期卵巢癌
err2025-12-09
err0
PREAI
errP. Harter; F. Trillsch; A. Okamoto; A. Reuss; J.-W. Kim; M.J. Rubio-Pérez; M.A. Vardar; G. Scambia; O. Trédan; G.-B. Nyvang; N. Colombo; M. Bidziński; C. Grimm; S. Lheureux; E. Van Nieuwenhuysen; F. Heitz; R.M. Wenham; S. Nishio; M.C. Lim; G. Marquina
err分享
err收藏
Long non-coding RNAs as a biomarker for homologous recombination deficiency and parp inhibitor sensitivity in high-grade serous ovarian cancers长链非编码RNA作为同源重组缺陷和PARP抑制剂敏感性的生物标志物,在高级别浆液性卵巢癌中的应用
err2025-10-01
err0
errOAAI
errKai Doberstein; Johannes Panther; Eric Hahnen; Lisa Richters; Philip C. Schouten; Philipp Harter; Florian Heitz; Stefan Kommoss; Sebastian Berlit; Benjamin Tuschy; Marc Sütterlin; Frederik Marmé
err分享
err收藏
Predictive value of BRCA1/RAD51C methylation in HGSOC – An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trialBRCA1/RAD51C甲基化在HGSOC中的预测价值——PAOLA-1/ENGOT-ov25 III期试验的附属研究
err2025-06-03
err0
PREAI
errH. Blons; J. Abdelli; S. Landman; V. Taly; C. Mulot; P. Laurent-Puig; B. You; P. Harter; D. Lorusso; Y. García-García; S. Polterauer; S. Hietanen; N. Colombo; I. Vergote; H. Kobayashi; T. De La Motte Rouge; P. Buderath; S.C. Cecere; G. Bataillon; E. Pujade-Lauraine; I. Ray-Coquard
err分享
err收藏
German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)德国S2k指南:关于低级别阑尾黏液性肿瘤(LAMN)的诊断、治疗和随访
err2025-06-01
err0
PREAI
errKoehler, Franziska; Arnold, Dirk; Aust, Daniela; Betge, Johannes; Brecht, Ines B.; Germer, Christoph-Thomas; Grouven, Bernd; Harter, Philipp; Kasper-Virchow, Stefan; Koslowski, Kai; Neeff, Hannes Philipp; Neumann, Jens; Piso, Pompiliu; Rau, Beate; Schneider, Dominik T.; Schreyer, Andreas G.; Kroeplin, Maria A.; Wiegering, Armin
err分享
err收藏
Highlights from the 26th European Congress on Gynaecological Oncology in Rome: interview compilation of the ENYGO-IJGC editorial fellows第26届欧洲妇科肿瘤学大会在罗马的亮点:ENYGO-IJGC编辑团队成员的采访汇编
err2025-04-29
err0
PREAI
errMartina Aida Angeles; Esra Bilir; Ilker Kahramanoglu; Helena Obermair; Alexander Shushkevich; Núria Agustí; Aleksandra Strojna; Ana Luzarraga Aznar; David Viveros-Carreño; Nicolò Bizzarri; Andrej Cokan; Houssein El Hajj; Mathilde Del; Elena Rodríguez; Osnat Elyashiv; Stamatios Petousis; Joanna Kacperczyk-Bartnik; Manel Montesinos-Albert; Nadeem Abu-Rustum; Philipp Harter; Pedro T. Ramirez
err分享
err收藏
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancerGOG-3097/ENGOT-ov81/GTG-UK/RAMP 301:一项评估阿伏莫替尼联合达法他尼与研究者选择治疗方案相比,在复发性低级别浆液性卵巢癌患者中的随机III期试验
err2025-04-19
err0
errOAAI
errRachel Grisham; Bradley J. Monk; Els Van Nieuwenhuysen; Kathleen Nadine Moore; Michel Fabbro; David M. O’Malley; Ana Oaknin; Premal Thaker; Amit M. Oza; Nicoletta Colombo; David Gershenson; Carol A. Aghajanian; Chel Hun Choi; Yeh Chen Lee; Mansoor Raza Mirza; Robert L. Coleman; Lauren Cobb; Philipp Harter; Stephanie Lustgarten; Hagop Youssoufian; Susana Banerjee
err分享
err收藏
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer关于晚期卵巢癌维持治疗方案选择和护理模式的驱动因素共识
err2025-04-19
err0
errOAAI
errAlejandro Perez-Fidalgo; Barbara Schmalfeldt; Angela George; Charlie Gourley; Sandro Pignata; Domenica Lorusso; Maria Pilar Barretina-Ginesta; Ignacio Romero; Christoph Grimm; Toon Van Gorp; Maria Rossing; Dearbhaile C. Collins; Josefin Fernebro; Line Bjørge; Alexandra Leary; Thibault de la Motte Rouge; Philipp Harter; Christian Kurzeder; Joana Savva-Bordalo; Benoit You
err分享
err收藏
Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group - Real-world observations
errEJSO
IF2.9
err2025-02-01
err0
errOAAI
errWimberger, Pauline; Pfisterer, Jacobus; du Bois, Andreas; Hilpert, Felix; Kerkmann, Markus; Sehouli, Jalid; Mahner, Sven; de Gregorio, Nikolaus; Hanker, Lars; Heitz, Florian; Marme, Frederik; Woelber, Linn; Holtmann, Laura; Elser, Gabriele; Harter, Philipp
err分享
err收藏
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ ENGOT-ov25 trial在完成奥拉帕利一线维持治疗后复发的晚期卵巢癌患者中后续治疗的有效性:PAOLA-1/ENGOT-ov25试验的结果
err2025-02-01
err2
errOAAI
errHarter, P.; Marth, C.; Mouret-Reynier, M. -A.; Cropet, C.; Lorusso, D.; Guerra-Alia, E. M.; Matsumoto, T.; Vergote, I.; Colombo, N.; Maenpaa, J.; Lebreton, C.; de Gregorio, N.; Mosconi, A. M.; Rubio-Perez, M. J.; Bourgeois, H.; Fasching, P. A.; Cecere, S. C.; Hardy-Bessard, A. C.; Denschlag, D.; de Percin, S.; Hanker, L.; Favier, L.; Bauerschlag, D.; Desauw, C.; Hillemanns, P.; Largillier, R.; Sehouli, J.; Grenier, J.; Pujade-Lauraine, E.; Ray-Coquard, I.
err分享
err收藏
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes多久才算足够长?一项国际调查,探讨在铂敏感复发性卵巢癌患者中,使用PARP抑制剂维持治疗推荐时长与实践差异及长期结局的关系。
err2024-12-01
err0
PREAI
errHaggstrom, Lucy; Lee, Yeh Chen; Scott, Clare; Harter, Philipp; Woelber, Linn; Gourley, Charlie; McNeish, Iain A.; Ray-Coquard, Isabelle; Leary, Alexandra; Oza, Amit M.; Tinker, Anna; Gonzalez Martin, Antonio; Cecere, Sabrina Chiara; Pignata, Sandro; Colombo, Nicoletta; Yoshida, Hiroyuki; Marth, Christian; Rosengarten, Ora; Moore, Kathleen Nadine; Gomez-Garcia, Eva Maria; Tan, David
err分享
err收藏
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer低覆盖率全基因组检测卵巢癌同源重组缺陷的临床评价
err2024-05-01
err0
errOAAI
errBoidot, Romain; Blum, Michael G. B.; Wissler, Marie-Pierre; Gottin, Celine; Ruzicka, Jiri; Chevrier, Sandy; Delhomme, Tiffany M.; Audoux, Jerome; Jeanniard, Adrien; Just, Pierre-Alexandre; Harter, Philipp; Pignata, Sandro; Gonzalez-Martin, Antonio; Marth, Christian; Maenpaa, Johanna; Colombo, Nicoletta; Vergote, Ignace; Fujiwara, Keiichi; Duforet-Frebourg, Nicolas; Bertrand, Denis; Philippe, Nicolas; Ray-Coquard, Isabelle; Pujade-Lauraine, Eric
err分享
err收藏
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium
err2024-04-27
err0
errOAAI
errObermayr, Eva; Mohr, Thomas; Schuster, Eva; Braicu, Elena Ioana; Taube, Eliane; Sehouli, Jalid; Vergote, Ignace; Pujade-Lauraine, Eric; Ray-Coquard, Isabelle; Harter, Philipp; Wimberger, Pauline; Joly-Lobbedez, Florence; Mahner, Sven; Moll, Ute Martha; Concin, Nicole; Zeillinger, Robert
err分享
err收藏
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian CancerdDevelopment of Recommendations for Optimal Assay Performance
err2024-04-01
err2
errOAAI
errRomey, Marcel; Rodepeter, Fiona; Hattesohl, Akira; Kaiser, Kristin; Teply-Szymanski, Julia; Heitz, Florian; Staebler, Annette; Serra, Violeta; Grass, Albert; Marme, Frederik; Timms, Kirsten M.; Harter, Philipp; Llop-Guevara, Alba; Kommoss, Stefan; Boekhoff, Jelena; Denkert, Carsten
err分享
err收藏
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseESGO-ESMO-ESP共识会议关于卵巢癌的建议: 病理学和分子生物学以及早期,晚期和复发性疾病
err2024-03-01
err46
errOAAI
errLedermann, J. A.; Matias-Guiu, X.; Amant, F.; Concin, N.; Davidson, B.; Fotopoulou, C.; Gonzalez-Martin, A.; Gourley, C.; Leary, A.; Lorusso, D.; Banerjee, S.; Chiva, L.; Cibula, D.; Colombo, N.; Croce, S.; Eriksson, A. G.; Falandry, C.; Fischerova, D.; Harter, P.; Joly, F.; Lazaro, C.; Lok, C.; Mahner, S.; Marme, F.; Marth, C.; McCluggage, W. G.; Mcneish, I. A.; Morice, P.; Nicum, S.; Oaknin, A.; Perez-Fidalgo, J. A.; Pignata, S.; Ramirez, P. T.; Ray-Coquard, I.; Romero, I.; Scambia, G.; Sehouli, J.; Shapira-Frommer, R.; Sundar, S.; Tan, D. S. P.; Taskiran, C.; van Driel, W. J.; Vergote, I.; Planchamp, F.; Sessa, C.; Fagotti, A.
err分享
err收藏
Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies68Ga-FAPI与18F-FDG PET在各种恶性肿瘤患者中的诊断准确性
err2024-02-08
err5
errOAAI
errHirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kuemmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Gruenwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.
err分享
err收藏
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles
err2023-12-01
err3
errOAAI
errPozzorini, Christian; Andre, Gregoire; Coletta, Tommaso; Buisson, Adrien; Bieler, Jonathan; Ferrer, Loic; Kempfer, Rieke; Saintigny, Pierre; Harle, Alexandre; Vacirca, Davide; Barberis, Massimo; Gilson, Pauline; Roma, Cristin; Saitta, Alexandra; Smith, Ewan; Barras, Floriane Consales; Ripol, Lucia; Fritzsche, Martin; Marques, Ana Claudia; Alkodsi, Amjad; Marin, Ray; Normanno, Nicola; Grimm, Christoph; Mullauer, Leonhard; Harter, Philipp; Pignata, Sandro; Gonzalez-Martin, Antonio; Denison, Ursula; Fujiwara, Keiichi; Vergote, Ignace; Colombo, Nicoletta; Willig, Adrian; Pujade-Lauraine, Eric; Just, Pierre-Alexandre; Ray-Coquard, Isabelle; Xu, Zhenyu
err分享
err收藏